# Esperion – FDA Inspection, Aug 9, 2019

Source: https://www.keypedia.com/records/fda_inspections/esperion/2646faaa-0494-4855-a29e-ac33b4a3b2d4
Source feed: FDA_Inspections

> FDA inspection 1099175 of Esperion, August 09, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099175
- Company Name: Esperion
- Inspection Date: 2019-08-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1174620 - 2022-06-29

## Related Officers

- [Company Rep](https://www.keypedia.com/people/camille-d-brown/419869d2-1810-40ea-8e8a-687de7013f6a)
- [FDA Associated Person](https://www.keypedia.com/people/myra-k-casey/a2fae714-2ba3-4c60-9f54-990fc7b169c9)

Company: https://www.keypedia.com/companies/esperion/38e07824-a42d-47e7-a8e4-6070ad6cf993

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c